                         SEQUENCE LISTING

<110>  Idera Pharmaceuticals Inc.
       CHUNDURU, Srinivas
 
<120>  USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19

<130>  105968-5179-WO

<150>  US 63/115,264
<151>  2020-11-18

<150>  US 63/008,305
<151>  2020-04-10

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (11)..(12)
<223>  Linked by is a glycerol linker

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (16)..(16)
<223>  2'-deoxy-7-deazaguanosine

<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  2'-deoxy-7-deazaguanosine

<400>  1
tcgaacgttc ggcttgcaag ct                                                22


